Naoshi Nishina

Initial predictors of poor survival in myositis-associated interstitial lung disease: a multicentre cohort of 497 patients

Shinji Sato, Kenichi Masui, Naoshi Nishina et al. · Lara D. Veeken · 2018 · 159 citations · Full text

Medicine, Immunology, Internal Medicine +17

Risk Prediction Modeling Based on a Combination of Initial Serum Biomarker Levels in Polymyositis/Dermatomyositis–Associated Interstitial Lung Disease

Takahisa Gono, Kenichi Masui, Naoshi Nishina et al. · Arthritis & Rheumatology · 2020 · 138 citations

Medicine, Immunology, Internal Medicine +17

Peripheral blood CD4+CD25+CD127low regulatory T cells are significantly increased by tocilizumab treatment in patients with rheumatoid arthritis: increase in regulatory T cells correlates with clinical response

Jun Kikuchi, Misato Hashizume, Yuko Kaneko et al. · Arthritis Research & Therapy · 2015 · 118 citations · Full text

Life Sciences, Clinical Sciences, Immunology +17

Reduction of plasma IL-6 but not TNF-α by methotrexate in patients with early rheumatoid arthritis: a potential biomarker for radiographic progression

Naoshi Nishina, Yuko Kaneko, Hideto Kameda et al. · Clinical Rheumatology · 2013 · 76 citations

Life Sciences, Clinical Sciences, Immunology +17

Seasonal and residential clustering at disease onset of anti-MDA5-associated interstitial lung disease

Naoshi Nishina, Shinji Sato, Kenichi Masui et al. · RMD Open · 2020 · 67 citations · Full text

Life Sciences, Immunology, Internal Medicine +17